ERBB2 and breast cancer: Further studies described follistatin, an intrinsic inhibitor of Mstn and Activin A, as a metastases suppressor in a HER2-positive BC mouse model, supporting our hypothesis that antibody-mediated inhibition of Mstn may affect tumor growth in the xenograft BC model [26].